Timothy Ricketts, MD
Internal Medicine · Hoover, ALNPI 1912014259
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,975 of the $3,305 with a category attached, or 90.0%. Shionogi Inc accounts for 90.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $1,750 and has fallen 99.2% since, to $14 in 2025.
Across 21 payments — averaging $157.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shionogi Inc$3K
- Novo Nordisk$77
- Bayer$61
- GSK$39
- Antares Pharma, Inc.$38
- AstraZeneca$34
- plus $81 from 5 others
Across 9 payments — averaging $36,671 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$284K
- AstraZeneca$24K
- E.r. Squibb & Sons, L.L.C.$22K
What the payments were for
- Consulting fees$2,97590%
- Food & beverage$33010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shionogi Inc | 2 | $2,975 |
| Novo Nordisk | 4 | $77 |
| Bayer | 4 | $61 |
| GSK | 2 | $39 |
| Antares Pharma, Inc. | 2 | $38 |
| AstraZeneca | 2 | $34 |
| Exact Sciences | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Shield Therapeutics Inc | 1 | $16 |
| Purdue Pharma L.p. | 1 | $14 |
| Dynavax Technologies Corporation | 1 | $13 |
How this compares
$3,305 in reported general payments places this provider in the 80th percentile of 1,533 internal medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 23 | $435 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 54 | $227 |
| Methylprednisolone | 26 | $222 |
| Ciprofloxacin Hcl | 22 | $182 |
| Azithromycin | 11 | $101 |
| Ondansetron Hcl | 11 | $29 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Hoover
- Amy IllescasHoover$20K
- Ryan WeldonBirmingham$458K
- Thomas McKelveyMobile$365K
- Mary HonkanenMobile$302K
- Robert LewisBirmingham$187K
- Rosalind BowlesGadsden$168K
- Sonja PettusJasper$117K
- Bobby WrightsMobile$89K
- Thomas HuddleBirmingham$76K
- Rahel AzizMobile$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.